Synonym
Danitracen; WA-335; WA 335; WA335; WA 335BS; BRN 1540021; NSC 170955.
IUPAC/Chemical Name
9,10-Dihydro-10-(1-methyl-4-piperidylidene)-9-anthrol
InChi Key
HLBRHTFSMMEHPK-UHFFFAOYSA-N
InChi Code
InChI=1S/C20H21NO/c1-21-12-10-14(11-13-21)19-15-6-2-4-8-17(15)20(22)18-9-5-3-7-16(18)19/h2-9,20,22H,10-13H2,1H3
SMILES Code
OC1C2=C(C=CC=C2)/C(C3=CC=CC=C13)=C4CCN(C)CC\4
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
Preparing Stock Solutions
The following data is based on the
product
molecular weight
291.39
Batch specific molecular weights may vary
from batch to batch
due to the degree of hydration, which will
affect the solvent
volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass |
1 mg |
5 mg |
10 mg |
| 1 mM |
1.15 mL |
5.76 mL |
11.51 mL |
| 5 mM |
0.23 mL |
1.15 mL |
2.3 mL |
| 10 mM |
0.12 mL |
0.58 mL |
1.15 mL |
| 50 mM |
0.02 mL |
0.12 mL |
0.23 mL |
1: Rao SG, Hrishikeshavan HJ, Guruswami MN. Effect of serotonergic agents on neuroleptic induced catalepsy in rats. Funct Neurol. 1990 Oct-Dec;5(4):353-60. PubMed PMID: 1982664.
2: Ogren SO, Berge OG. Evidence for selective serotonergic receptor involvement in p-chloroamphetamine-induced antinociception. Naunyn Schmiedebergs Arch Pharmacol. 1985 Apr;329(2):135-40. PubMed PMID: 4010792.
3: Ogren SO, Carlsson S, Bartfai T. Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse. Psychopharmacology (Berl). 1985;86(3):258-64. PubMed PMID: 3929296.
4: Hrishi Keshavan HJ, Gurbani NK, Dandiya PC. Neurochemical effects of danitracen (WA-355): mechanism of action. J Neural Transm. 1982;53(2-3):217-21. PubMed PMID: 6176681.
5: Desiles M, Rips R. Use of potentiation of thyrotrophin releasing hormone (TRH)-induced hyperthermia as a test for screening antidepressants which activate alpha-adrenoceptor systems. Br J Pharmacol. 1981 Sep;74(1):81-6. PubMed PMID: 6115696; PubMed Central PMCID: PMC2071883.
6: Przegaliński E, Kordecka-Magiera A, Mogilnicka E, Maj J. Chronic treatment with some atypical antidepressants increases the brain level of 3-methoxy-4-hydroxyphenylglycol (MHPG) in rats. Psychopharmacology (Berl). 1981;74(2):187-90. PubMed PMID: 6791225.
7: Turski L, Turski W, Czuczwar SJ, Kleinrok Z. Evidence against the involvement of serotonergic mechanisms in wet dog shake behavior induced by carbachol chloride in rats. Psychopharmacology (Berl). 1981;73(4):376-80. PubMed PMID: 6454900.
8: Chodera A, Cenajek D, Mazurek K. Interaction of parachlorophenylalanine, mianserine and danitracen with amphetamine. Arzneimittelforschung. 1981;31(1):61-3. PubMed PMID: 6452129.
9: Stach R, Lazarova MB, Kacz D. The effects of antidepressant drugs on the seizures kindled from the rabbit amygdala. Pol J Pharmacol Pharm. 1980 Jul-Aug;32(4):505-12. PubMed PMID: 7255268.
10: Górka Z, Wojtasik E. The effect of antidepressants on behavioral despair in rats. Pol J Pharmacol Pharm. 1980 Jul-Aug;32(4):463-8. PubMed PMID: 7196038.
11: Gold R, Morgenstern R, Fink H. Effects of atypical antidepressants on LSD potentiated apomorphine hypermotility in rats. Acta Biol Med Ger. 1980;39(8-9):917-21. PubMed PMID: 6456637.
12: Zandarowska E, Nowak JZ, Bielkiewicz B. Lack of influence of histamine H1-, and H2-receptor antagonists on histamine level in rat brain. Arch Immunol Ther Exp (Warsz). 1980;28(6):931-4. PubMed PMID: 6114723.
13: Mogilnicka E, Klimek V. Mianserin, danitracen and amitriptyline withdrawal increases the behavioural responses of rats to L-5-HTP. J Pharm Pharmacol. 1979 Oct;31(10):704-5. PubMed PMID: 41046.
14: Maj J, Mogilnicka E, Kordecka A. Chronic treatment with antidepressant drugs: potentiation of apomorphine-induced aggressive behaviour in rats. Neurosci Lett. 1979 Aug;13(3):337-41. PubMed PMID: 575199.
15: Pawłowski L, Ruczyńska J, Wojtasik E. An evidence for the central serotoninergic activity of viloxazine. Pol J Pharmacol Pharm. 1979 Jul-Aug;31(4):261-9. PubMed PMID: 523336.
16: Mogilnicka E, Klimek V. Effect of chronic administration of antidepressant drugs on the noradrenaline disappearance induced by FLA-63 in the rat brain. Pol J Pharmacol Pharm. 1979 Mar-Apr;31(2):139-47. PubMed PMID: 158750.
17: Przegaliński E, Lewandowska A. The effect of etoperidone, a new potential antidepressant drug, on the central serotonin system. J Neural Transm. 1979;46(4):303-12. PubMed PMID: 529000.
18: Baran L, Maj J, Rogóz Z, Skuza G. On the central antiserotonin action of trazodone. Pol J Pharmacol Pharm. 1979 Jan-Feb;31(1):25-33. PubMed PMID: 482164.
19: Maj J, Mogilnicka E, Klimek V. The effect of repeated administration of antidepressant drugs on the responsiveness of rats to catecholamine agonists. J Neural Transm. 1979;44(3):221-35. PubMed PMID: 438808.
20: Wielosz M, Przegalinski E, Kleinrok Z. In vivo effect of danitracen on the uptake mechanism in monoaminergic neurons and platelets in rats. Agressologie. 1979;20(D):253-7. PubMed PMID: 162446.
